Gilead releases highly anticipated pricing for Coronavirus Remdesivir treatment

Published by : Fox Business
Fox News medical contributor Dr. Marc Siegel comments on Gilead Sciences' pricing coronavirus Remdesivir drug at $390 per vial and discusses concern for spiking cases in the U.S.

Subscribe to Fox Business!
Watch more Fox Business Video:
Watch Fox Business Network Live:

FOX Business Network (FBN) is a financial news channel delivering real-time information across all platforms that impact both Main Street and Wall Street. Headquartered in New York — the business capital of the world — FBN launched in October 2007 and is one of the leading business networks on television, having topped CNBC in Business Day viewers for the second consecutive year in 2018. The network is available in nearly 80 million homes in all markets across the United States. Owned by FOX Corporation, FBN is a unit of FOX News Media and has bureaus in Chicago, Los Angeles, and Washington, D.C.

Watch full episodes of FBN Primetime shows
Lou Dobbs Tonight:

Follow Fox Business on Facebook:
Follow Fox Business on Twitter:
Follow Fox Business on Instagram:
cached video

Fox Business Network Fox Business Business News industries Stuart Varney Varney and Co Remdesivir Gilead Gilead sciences coronavirus treatment Coronavirus Coronavirus treatment coronavirus bill public health public health crisis covid 19 coronavirus cases us health global health coronavirus pandemic coronavirus quarantine social distancing coronavirus relief bill coronavirus peak coronavirus vaccine vaccines medical supplies